David R. Ebsworth - 01 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Reporting relationship: Director
Issuer ticker: VRNA
Reported as of: 01 Aug 2025
Net transaction value: -$25,026
SEC form: 4
Accepted by SEC: 05 Aug 2025, 20:21:38 UTC
Prior SEC filing: 05 May 2025
Next SEC filing: 08 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth

Key filing fact

David R. Ebsworth filed Form 4 for Verona Pharma plc (VRNA) on 05 Aug 2025.

Key facts

This page summarizes David R. Ebsworth's Form 4 filing for Verona Pharma plc (VRNA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2025, 20:21.

Change

Previous filing in this sequence was filed on 05 May 2025.
Current net transaction value: -$25,026.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001207107 Primary reporting owner

EBSWORTH DAVID R

Relationship: Director
Address: 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM
Signature: /s/ Andrew Fisher, Attorney-in-fact for David R. Ebsworth
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRNA transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +24,000
Change %: +2.8%
Price: $0.000000
Shares after: 882,403
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1, F2

VRNA transaction

Ordinary Shares

Sale

Transaction value: $25,026
Shares: -1,904
Change %: -0.22%
Price: $13.14
Shares after: 880,499
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1, F3, F4, F5

VRNA holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 617,600
Date: 01 Aug 2025
Ownership: By Ebsworth GmbH
Footnotes: F1, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRNA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -24,000
Change %: -25%
Price: $0.000000
Shares after: 72,000
Date: 01 Aug 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 24,000
Exercise price
Footnotes: F1, F7, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

Footnote F2

Excludes 617,600 Ordinary Shares represented by 77,200 ADSs that were transferred from the Reporting Person to a limited liability company of which the Reporting Person is the sole shareholder.

Footnote F3

The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the Reporting Person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").

Footnote F4

The price reported represents the sale price of the ADSs divided by eight (8).

Footnote F5

Consists of (i) 880,496 Ordinary Shares represented by 110,062 ADSs and (ii) 3 Ordinary Shares.

Footnote F6

Consists of 617,600 Ordinary Shares represented by 77,200 ADSs.

Footnote F7

Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.

Footnote F8

The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.

SEC remarks

Exhibit 24 - Power of Attorney.